TY - JOUR
T1 - Surgical versus medical treatment for children with epileptic encephalopathy in infancy and early childhood
T2 - Results of an international multicenter cohort study in Far-East Asia (the FACE study)
AU - Otsuki, Taisuke
AU - Kim, Heung Dong
AU - Luan, Guoming
AU - Inoue, Yushi
AU - Baba, Hiroshi
AU - Oguni, Hirokazu
AU - Hong, Seung Chyul
AU - Kameyama, Shigeki
AU - Kobayashi, Katsuhiro
AU - Hirose, Shinichi
AU - Yamamoto, Hitoshi
AU - Hamano, Shin ichiro
AU - Sugai, Kenji
N1 - Funding Information:
This study was supported by the following Health Labor Sciences Research grants from the Ministry of Health, Labour and Welfare of Japan: (1) H21-nanchi-ippan-156, (2) H22-nanchi-ippan-063, and (3) H24-nanchitou-ippan-029.
PY - 2016/5/1
Y1 - 2016/5/1
N2 - Objective To compare the seizure and developmental outcomes in infants and young children with epileptic encephalopathy who have undergone surgical and medical treatments. Methods An international, multicenter, observational cohort study was undertaken. A total of 317 children aged <6 years, who had frequent disabling seizures despite intensive medical treatments, were registered. Among the enrolled children, 250 were treated medically (medical group), 31 underwent resective surgery (resective group), and 36 underwent palliative surgery [callosotomy (n = 30) or vagal nerve stimulation (n = 6); palliative group] on admission. Seizure and developmental outcomes were obtained for 230 children during the 3-year follow-up period. Cox proportional hazard model was used to adjust for clinical backgrounds among treatment groups when comparing the seizure-free survival rates. Results At the 3-year follow-up, seizure-free survival was 15.7%, 32.1%, and 52.4% in the medical, palliative, and resective groups, respectively. The adjusted hazard ratios for seizure recurrence in the resective and palliative groups versus the medical group were 0.43 (95% CI, 0.21–0.87, P = 0.019) and 0.82 (95% CI, 0.46–1.46, P = 0.50), respectively; the former was statistically significant. Regarding the developmental outcome, the mean DQs in the resective group increased significantly compared to those in the medical group during the follow-up (P < 0.01). As for subgroup analysis, better seizure and development outcomes were demonstrated in the resective group compared to the medical group in children with nonsyndromic epilepsies (those to which no known epilepsy syndromes were applicable). Significance These results suggest that surgical treatments, particularly resective surgeries, are associated with better seizure and developmental outcomes compared with successive medical treatment. The present observations may facilitate the identification of infants and young children with epileptic encephalopathy who could benefit from surgery.
AB - Objective To compare the seizure and developmental outcomes in infants and young children with epileptic encephalopathy who have undergone surgical and medical treatments. Methods An international, multicenter, observational cohort study was undertaken. A total of 317 children aged <6 years, who had frequent disabling seizures despite intensive medical treatments, were registered. Among the enrolled children, 250 were treated medically (medical group), 31 underwent resective surgery (resective group), and 36 underwent palliative surgery [callosotomy (n = 30) or vagal nerve stimulation (n = 6); palliative group] on admission. Seizure and developmental outcomes were obtained for 230 children during the 3-year follow-up period. Cox proportional hazard model was used to adjust for clinical backgrounds among treatment groups when comparing the seizure-free survival rates. Results At the 3-year follow-up, seizure-free survival was 15.7%, 32.1%, and 52.4% in the medical, palliative, and resective groups, respectively. The adjusted hazard ratios for seizure recurrence in the resective and palliative groups versus the medical group were 0.43 (95% CI, 0.21–0.87, P = 0.019) and 0.82 (95% CI, 0.46–1.46, P = 0.50), respectively; the former was statistically significant. Regarding the developmental outcome, the mean DQs in the resective group increased significantly compared to those in the medical group during the follow-up (P < 0.01). As for subgroup analysis, better seizure and development outcomes were demonstrated in the resective group compared to the medical group in children with nonsyndromic epilepsies (those to which no known epilepsy syndromes were applicable). Significance These results suggest that surgical treatments, particularly resective surgeries, are associated with better seizure and developmental outcomes compared with successive medical treatment. The present observations may facilitate the identification of infants and young children with epileptic encephalopathy who could benefit from surgery.
KW - Developmental quotient
KW - Epilepsy surgery
KW - Epileptic encephalopathy
KW - Prospective cohort study
KW - Seizure outcome
UR - http://www.scopus.com/inward/record.url?scp=84949665562&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84949665562&partnerID=8YFLogxK
U2 - 10.1016/j.braindev.2015.11.004
DO - 10.1016/j.braindev.2015.11.004
M3 - Article
C2 - 26686601
AN - SCOPUS:84949665562
SN - 0387-7604
VL - 38
SP - 449
EP - 460
JO - Brain and Development
JF - Brain and Development
IS - 5
ER -